Maria Τektonidou: TMN Manifestation Scores and Mortality in Antiphospholipid Syndrome
Maria Τektonidou, Professor of Rheumatology at National and Kapodistrian University of Athens, shared a post on LinkedIn, about a recent article she and her colleagues co-authored, adding:
“Further Validation of the Eular Antiphospholipid syndrome disease activity score (Eapsdas). Criterion Validity using mortality as the criterion.
The maximum scores of thrombotic/microvascular/non-thrombotic (TMN) manifestations were significantly higher among patients who died due to Antiphospholipid Syndrome than among those who survived and those who died from other causes”
Title: Criterion validity of the EULAR Antiphospholipid Syndrome Disease Activity Score (EAPSDAS)
Authors: Maria G. Tektonidou, Ricard Cervera , Guillermo J. Pons-Estel , Savino Sciascia, Angela Tincani , Michael M. Ward
Read the Full Article on Annals of the Rheumatic Diseases
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 25, 2026, 07:25Varun Capoor: How Therapeutic Apheresis and Transfusion Medicine Can Complement Clinical Management in SCD
-
Sep 25, 2026, 07:14Manshi Kesharwani: SAK-GQDs Modulate Thrombus Burden and Endothelial Function in Deep Vein Thrombosis
-
Sep 25, 2026, 06:20Farjah Hassan Algahtani: How Can We Better Identify Patients at Risk of Blood Clots after Metabolic and Bariatric Surgery?
-
Sep 25, 2026, 05:59Carla Lewis: Kids Conquering Sickle Disease Joins Nemours Children’s Hospital for 2nd Annual Awareness Event
-
Sep 25, 2026, 05:47Omid Seidizadeh: Evolutionary Constraint and Population Variation Across Coagulation Genes
-
Sep 25, 2026, 05:40Gerald Bertrand: Presenting UMi-NGS Non-Invasive Foetal HPA Genotyping at DGTI 2026
-
Sep 25, 2026, 05:33Urge Congress to support the Sickle Cell Disease Comprehensive Care Act – ASH
-
Sep 25, 2026, 05:24Isabelle Mahé: Reduced-Dose Apixaban in Extended CAT Treatment
-
Sep 25, 2026, 05:15Maria Cherska: High Cholesterol Isn’t Always Diet or Lifestyle – Sometimes It’s Genetic